US EditionUniquely engineered KRAS-targeted cancer drug found to be effective in early studies - UNC Lineberger
Summary by unclineberger.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies - UNC Lineberger
Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KARS-G12V could potentially stop KRAS-dependent cancers in their tracks. The post Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies appeared first on UNC Lineberger.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
